United Immunity

United Immunity is a clinical-stage biotechnology company based in Tokyo that develops in vivo immunotherapies targeting myeloid cells. Its proprietary Myeloid Targeting Platform uses nanoparticles to selectively deliver therapeutic agents to immune cells such as macrophages and dendritic cells. The company is advancing UI-102, a pullulan-nanoparticle TLR7/8 agonist in Phase 1/2 development for advanced solid tumors, alongside in vivo CAR-macrophage programs for cancer and fibrotic diseases.

  • Series A
  • Biotechnology
  • Clinical Trials
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Sep 24, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Sep 24, 2026

    JPY 11.3M

    Series A

    • Fujita TT Impact No.1 Investment LP
    • ITOCHU Corporation
    • Kobe University Capital
    • Mitsubishi UFJ Capital
    • Miyako Capital
    • Mizuho Capital
    • Nippon Venture Capital
    • Ono Venture Investment (OVI)
    • Ricoh Biomedical Startup Investment Fund (Ricoh CVC)
    • Saisei Bioventures
    • UTEC

    Article coming soon.

Pricing

Research United Immunity — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Get started

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Get started

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if United Immunity is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

Start freeAll fundingVisit website
© 2026 VeilStrat. All rights reserved.All systems operational